Cabozantinib a Viable Choice for Non-Clear Cell Renal Cell Carcinoma
There are no biomarkers ready that have been prospectively validated to help predict which patients with non-clear cell RCC might respond to cabozantinib.
Renal Cell Carcinoma
RENAL CELL CARCINOMA ADVISOR
FEATURED CONTENT
-
-
Predicting PD-1/PD-L1 Immunotherapy Responses
Finding biomarkers that can broadly and reliably predict immunotherapy outcomes for patients with cancer remains an elusive “holy grail,” said Dr Ott. -
Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
Concerns about conflict of interest as it relates to prescribing may never go away, some say, as long as drug companies offer doctors money for consulting and personal services. -
Opinion: Understanding the FDA’s Take on Cannabidiol
In a statement announcing a newly created partnership, the Botanical Safety Consortium, FDA Commissioner Scott Gottlieb made no mention of cannabidiol. -
Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing
“People have shown that the variant-identification quality of WGS is superior to WES,” said Dr Gerstein.
VIDEO SERIES
Tivozanib for RCC
Genitourinary Oncology: A Peek Over the Horizon
Immunotherapy of Renal Cell Carcinoma
Targeted Therapies for Renal Cell Carcinoma
Genetics and Heterogeneity
Genetic Predisposition to Kidney Cancers
Personalized Medicines for Kidney Cancers
Drugs in the Pipeline
Resistance to Therapy Among Kidney Cancers
Targeted Therapy
The Role of Neoadjuvant Tx
Sx Options – Ablative Techniques
Sx Options – Lymph Node
Sx Options – Cytoreductive Nephrectomy
TKIs – First-Line Therapy
TKIs – Second-Line Therapy
Biomarkers in RCC
The MET Pathway
Checkpoint Inhibitors
RENAL CELL CARCINOMA NEWS
Tivozanib Offers Superior Outcomes in Refractory Metastatic Renal Cell Carcinoma
First-Line Pembrolizumab Shows Promise in Non-Clear Cell RCC
Early Tumor Shrinkage With Cabozantinib Improves Survival in Renal Cell Carcinoma
Combo Superior to Sunitinib in Advanced Renal Cell Carcinoma
Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed
Want to read more?
Please login or register first to view this content.
Next post in Renal Cell Carcinoma
